回复：朗达·L·比廷、帕特里克·希利、丹尼尔·J·乔治等。恩杂鲁胺与雄激素剥夺疗法联合挽救性放疗用于高风险前列腺特异性抗原复发前列腺癌男性患者的II期试验：STREAM试验。《欧洲泌尿外科肿瘤学杂志》2021年；4：948 - 54。 - Suppr

Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948-54.

作者信息

Guler Ozan Cem, Isci Oguzhan, Onal Cem

机构信息

Department of Radiation Oncology, Baskent University Faculty of Medicine, Adana Dr. Turgut Noyan Research and Treatment Center, Adana, Turkey.

Department of Radiation Oncology, Dicle University Faculty of Medicine, Diyarbakir, Turkey.

出版信息

Eur Urol Oncol. 2022 Aug;5(4):477-478. doi: 10.1016/j.euo.2022.03.002. Epub 2022 Mar 17.

DOI:10.1016/j.euo.2022.03.002

PMID:35307322

Abstract

摘要

相似文献

Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948-54.回复：朗达·L·比廷、帕特里克·希利、丹尼尔·J·乔治等。恩杂鲁胺与雄激素剥夺疗法联合挽救性放疗用于高风险前列腺特异性抗原复发前列腺癌男性患者的II期试验：STREAM试验。《欧洲泌尿外科肿瘤学杂志》2021年；4：948 - 54。

Eur Urol Oncol. 2022 Aug;5(4):477-478. doi: 10.1016/j.euo.2022.03.002. Epub 2022 Mar 17.

Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial.高危前列腺特异抗原复发前列腺癌患者中恩杂鲁胺和雄激素剥夺治疗联合挽救性放疗的 II 期临床试验：STREAM 试验。

Eur Urol Oncol. 2021 Dec;4(6):948-954. doi: 10.1016/j.euo.2020.01.005. Epub 2020 Feb 13.

Re: Liam Bourke, Stephen Gilbert, Richard Hooper, et al. Lifestyle changes for improving disease-specific quality of life in sedentary men on long-term androgen-deprivation therapy for advanced prostate cancer: a randomised controlled trial. Eur Urol 2014;65:865-72; Re: Daniel A. Galvão, Nigel Spry, James Denham, et al. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR. Eur Urol 2014;65:856-64; Re: Nancy L. Keating, Pang-Hsiang Liu, A. James O'Malley, Stephen J. Freedland, Matthew R. Smith. Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancer. Eur Urol 2014;65:816-24; Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. Eur Urol 2014;65:704-9.回复：利亚姆·伯克、斯蒂芬·吉尔伯特、理查德·胡珀等人。生活方式改变对接受晚期前列腺癌长期雄激素剥夺治疗的久坐男性特定疾病生活质量的改善作用：一项随机对照试验。《欧洲泌尿外科杂志》2014年；65：865 - 872；回复：丹尼尔·A·加尔瓦奥、奈杰尔·斯普里、詹姆斯·德纳姆等人。一项针对接受过雄激素抑制和放疗的前列腺癌男性进行的为期一年的多中心随机对照试验，该试验以运动训练改善身体机能为目标（来自TROG 03.04 RADAR研究）。《欧洲泌尿外科杂志》2014年；65：856 - 864；回复：南希·L·基廷、刘庞祥、A·詹姆斯·奥马利、斯蒂芬·J·弗里德兰、马修·R·史密斯。前列腺癌男性糖尿病患者中的雄激素剥夺治疗与血糖控制。《欧洲泌尿外科杂志》2014年；65：816 - 824；回复：克里斯蒂娜·G·耶斯佩森、梅特·诺尔加德、迈克尔·博勒。前列腺癌治疗中的雄激素剥夺治疗与心肌梗死和中风风险：一项基于丹麦全国人口的队列研究。《欧洲泌尿外科杂志》2014年；65：704 - 709。

Eur Urol. 2014 Sep;66(3):e51-2. doi: 10.1016/j.eururo.2014.04.018. Epub 2014 May 10.

Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer: A Phase 2 Study.恩杂鲁胺联合放射治疗中危前列腺癌：一项 2 期研究。

Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1416-1422. doi: 10.1016/j.ijrobp.2021.02.027. Epub 2021 Feb 23.

Re: Bo Dai, Sheng Zhang, Fan-Ning Wan, et al. Combination of Androgen Deprivation Therapy with Radical Local Therapy Versus Androgen Deprivation Therapy Alone for Newly Diagnosed Oligometastatic Prostate Cancer : A Phase 2 Randomized Controlled Trial. Eur Urol Oncol 2022;5:519-25.

Eur Urol Oncol. 2023 Aug;6(4):451. doi: 10.1016/j.euo.2023.01.006. Epub 2023 Jan 25.

Enzalutamide with androgen deprivation therapy in Japanese men with metastatic hormone-sensitive prostate cancer: A subgroup analysis of the phase III ARCHES study.恩扎卢胺联合雄激素剥夺疗法治疗转移性激素敏感性前列腺癌日本男性患者：III 期 ARCHES 研究的亚组分析。

Int J Urol. 2021 Jul;28(7):765-773. doi: 10.1111/iju.14568. Epub 2021 May 6.

A phase 3 randomised study of enzalutamide plus leuprolide and enzalutamide monotherapy in high-risk non-metastatic hormone-sensitive prostate cancer with rising PSA after local therapy: EMBARK study design.一项局部治疗后 PSA 升高的高危非转移性激素敏感性前列腺癌中恩扎卢胺联合亮丙瑞林和恩扎卢胺单药治疗的 3 期随机研究：EMBARK 研究设计。

BMJ Open. 2021 Aug 12;11(8):e046588. doi: 10.1136/bmjopen-2020-046588.

Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93: Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients.回复：卡琳·韦伦、埃巴·罗森达尔、马格努斯·吉斯伦等人。抗雄激素疗法对COVID-19结局影响的2期试验：无获益证据，有流行病学和体外数据支持。《欧洲泌尿外科杂志》。2022年；81：285 - 93：恩杂鲁胺对住院COVID-19患者的积极作用

Eur Urol. 2022 Jun;81(6):e141-e142. doi: 10.1016/j.eururo.2022.01.049. Epub 2022 Feb 23.

Re: Jian Pan, Yu Wei, Tingwei Zhang, et al. Stereotactic Radiotherapy for Lesions Detected via Ga-Prostate-specific Membrane Antigen and F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Nonmetastatic Prostate Cancer with Early Prostate-specific Antigen Progression on Androgen Deprivation Therapy: A Prospective Single-center Study. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2022.02.002.

Eur Urol Oncol. 2022 Aug;5(4):475-476. doi: 10.1016/j.euo.2022.04.005. Epub 2022 May 14.

Re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891). Eur Urol 2008;53:941-9 and re: John Anderson. Androgen-deprivation therapy--It's all a matter of timing. Eur Urol 2008;53:869-71.

Eur Urol. 2009 Feb;55(2):e40-2; author reply e45-6. doi: 10.1016/j.eururo.2008.08.039. Epub 2008 Aug 24.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948-54.

作者信息

机构信息

出版信息

相似文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献